MESSA, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.014
AS - Asia 455
EU - Europa 345
AF - Africa 97
SA - Sud America 96
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.023
Nazione #
US - Stati Uniti d'America 945
SG - Singapore 163
CN - Cina 126
IT - Italia 79
BR - Brasile 54
DE - Germania 47
VN - Vietnam 35
HK - Hong Kong 34
FI - Finlandia 21
PL - Polonia 21
SE - Svezia 20
GB - Regno Unito 17
CI - Costa d'Avorio 16
NL - Olanda 16
ID - Indonesia 14
AR - Argentina 13
AT - Austria 12
RU - Federazione Russa 12
FR - Francia 11
IN - India 10
KR - Corea 10
CA - Canada 9
BE - Belgio 8
UY - Uruguay 8
AO - Angola 7
EG - Egitto 7
PT - Portogallo 7
AU - Australia 6
HR - Croazia 6
IE - Irlanda 6
LY - Libia 6
GP - Guadalupe 5
IS - Islanda 5
JP - Giappone 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
MX - Messico 5
MZ - Mozambico 5
PA - Panama 5
PY - Paraguay 5
RS - Serbia 5
VE - Venezuela 5
ZA - Sudafrica 5
BJ - Benin 4
BO - Bolivia 4
BZ - Belize 4
CY - Cipro 4
GR - Grecia 4
HN - Honduras 4
JM - Giamaica 4
MN - Mongolia 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BF - Burkina Faso 3
CD - Congo 3
CR - Costa Rica 3
DK - Danimarca 3
EC - Ecuador 3
ES - Italia 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LC - Santa Lucia 3
MD - Moldavia 3
ME - Montenegro 3
MQ - Martinica 3
MY - Malesia 3
NI - Nicaragua 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
TZ - Tanzania 3
UA - Ucraina 3
VC - Saint Vincent e Grenadine 3
YT - Mayotte 3
ZM - Zambia 3
AD - Andorra 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BD - Bangladesh 2
BS - Bahamas 2
CM - Camerun 2
CO - Colombia 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
DM - Dominica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
GM - Gambi 2
IQ - Iraq 2
KH - Cambogia 2
LU - Lussemburgo 2
MG - Madagascar 2
MK - Macedonia 2
Totale 1.966
Città #
Ashburn 119
Fairfield 116
Chandler 94
Singapore 91
Houston 80
Woodbridge 70
Seattle 59
Cambridge 47
Beijing 42
Hong Kong 32
Wilmington 32
Ann Arbor 31
Boardman 20
Santa Clara 20
Padova 19
Bytom 18
Abidjan 16
San Diego 13
Los Angeles 12
Berlin 11
Hefei 11
Helsinki 11
Medford 11
Munich 11
Princeton 11
Council Bluffs 10
Des Moines 10
Hanoi 10
Frankfurt am Main 9
Seoul 9
Columbus 8
Guangzhou 7
Ho Chi Minh City 7
Montevideo 7
Roxbury 7
Cagliari 6
Dublin 6
Montreal 6
Stockholm 6
Vienna 6
Amsterdam 5
Chicago 5
Luanda 5
Maputo 5
Nanjing 5
Vicenza 5
Brooklyn 4
Brussels 4
Cotonou 4
Dong Ket 4
Florence 4
London 4
Milan 4
Panama City 4
Reykjavik 4
Riga 4
Shanghai 4
Tokyo 4
Tripoli 4
Ulan Bator 4
Vientiane 4
Asunción 3
Athens 3
Baku 3
Boston 3
Buffalo 3
Cairo 3
Castries 3
Chisinau 3
Dallas 3
Dar es Salaam 3
Guatemala City 3
Haiphong 3
Johannesburg 3
Kingstown 3
Kinshasa 3
Kunming 3
Lappeenranta 3
Lusaka 3
Managua 3
Melbourne 3
Nicosia 3
Ouagadougou 3
Pune 3
San José 3
Shenyang 3
São Paulo 3
Turku 3
Warsaw 3
Zagreb 3
Accra 2
Andorra la Vella 2
Auckland 2
Bamako 2
Belize City 2
Bishkek 2
Blantyre 2
Bologna 2
Bratislava 2
Bridgetown 2
Totale 1.308
Nome #
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 233
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity 226
4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy 216
HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys 215
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 209
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 205
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 201
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 149
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 142
HPV-induced cancers: preclinical therapeutic advancements 135
Insights into the functionality and druggability of the homodimerization of human papillomavirus E6 oncoprotein 125
Totale 2.056
Categoria #
all - tutte 6.726
article - articoli 6.262
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.988


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 6 5 12 10 21 9 32 24
2021/2022168 3 6 27 22 15 8 3 21 2 8 18 35
2022/2023178 26 25 5 30 31 24 1 6 16 5 8 1
2023/2024125 0 19 18 7 8 16 14 9 4 11 4 15
2024/2025361 0 27 16 17 40 11 22 39 25 11 58 95
2025/2026732 94 112 168 229 129 0 0 0 0 0 0 0
Totale 2.056